Cabergoline-d5

• CAT Number: S000304
• CAS Number: 1426173-20-7
• Molecular Formula: C26H32D5N5O2
• Molecular Weight: 456.64
• Purity: ≥95%
• IUPAC Name: (6aR,9R)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-(1,1,2,3,3-pentadeuterioprop-2-enyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
• InChI: InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21?,23-/m1/s1/i1D2,5D,11D2
• InChIKey: KORNTPPJEAJQIU-WDORCQELSA-N
• SMILES: CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C

Cabergoline-d5（Cat No.:S000304） is a deuterated form of cabergoline, where five hydrogen atoms are replaced with deuterium, enhancing its molecular stability. This modification makes it an ideal internal standard for precise analytical techniques such as mass spectrometry and NMR spectroscopy. Cabergoline is a dopamine agonist used primarily to treat hyperprolactinemia (high levels of prolactin in the blood), Parkinson’s disease, and certain pituitary tumors. The use of cabergoline-d5 in research facilitates more accurate pharmacokinetic and metabolic studies, enabling detailed analysis of the drug’s absorption, distribution, metabolism, and excretion in biological systems.